Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia.
Serio, M
Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia. [electronic resource] - Molecular and cellular endocrinology Jun 1991 - C77-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0303-7207
10.1016/0303-7207(91)90174-q doi
5-alpha Reductase Inhibitors
Androgens--pharmacology
Androstenes--pharmacology
Azasteroids--pharmacology
Carcinoma--pathology
Cell Division--drug effects
Cells, Cultured
Dihydrotestosterone--metabolism
Epidermal Growth Factor--physiology
Finasteride
Gonadotropin-Releasing Hormone--analogs & derivatives
Growth Substances--pharmacology
Humans
Insulin-Like Growth Factor I--physiology
Male
Peptides--pharmacology
Prostate--pathology
Prostatic Hyperplasia--drug therapy
Prostatic Neoplasms--pathology
Tumor Cells, Cultured--drug effects
Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia. [electronic resource] - Molecular and cellular endocrinology Jun 1991 - C77-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0303-7207
10.1016/0303-7207(91)90174-q doi
5-alpha Reductase Inhibitors
Androgens--pharmacology
Androstenes--pharmacology
Azasteroids--pharmacology
Carcinoma--pathology
Cell Division--drug effects
Cells, Cultured
Dihydrotestosterone--metabolism
Epidermal Growth Factor--physiology
Finasteride
Gonadotropin-Releasing Hormone--analogs & derivatives
Growth Substances--pharmacology
Humans
Insulin-Like Growth Factor I--physiology
Male
Peptides--pharmacology
Prostate--pathology
Prostatic Hyperplasia--drug therapy
Prostatic Neoplasms--pathology
Tumor Cells, Cultured--drug effects